| Saturday, March 26, 2022 |
| 07:00 AM – 08:00 AM | Breakfast | |
| 08:00 AM – 08:10 AM | Introduction and Conference Goals | Michael S. Saag, MD |
| 08:10 AM – 08:35 AM | Antiretroviral Therapy: Starts, Switches and Rescues – Where Are We Now? | Joseph J. Eron Jr., MD |
| 08:35 AM – 09:00 AM | New Drugs for HIV | Connie Benson, MD |
| 09:00 AM – 09:20 AM | Panel Discussion / Questions and Answers | |
| 09:20 AM – 09:45 AM | Post-Conference Update from CROI 2022 | Rajesh T. Gandhi, MD |
| 09:45 AM – 10:00 AM | Break | |
| 10:00 AM – 10:25 AM | Hot Topics in Pharmacology: Drug Interactions | Charles W. Flexner, MD |
| 10:25 AM – 10:45 AM | Panel Discussion / Questions and Answers | |
| 10:45 AM – 11:10 AM | Update on Sexually Transmitted Infections | Jeanne Marrazzo, MD |
| 11:10 AM – 11:35 AM | Pre-exposure Prophylaxis for HIV Infection | Ronnie M. Gravett, MD |
| 11:35 AM – 11:55 AM | Panel Discussion / Questions and Answers | |
| 11:55 AM – 12:20 PM | Considerations for Patients with Substance Abuse | Glenn J. Treisman, MD, PhD |
| 12:20 PM – 12:30 PM | Panel Discussion / Questions and Answers | |
| 12:30 PM – 12:45 PM | Break | |
| 12:45 PM – 01:45 PM | Working Lunch - Case Presentations | Michael S. Saag, MD and faculty panel |
| 01:50 PM – 02:20 PM | Faculty Roundtable Session 1* | |
| 02:25 PM – 02:55 PM | Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the four sessions)
PrEP and Prevention: Therapeutics and Behavior | Jeanne Marrazzo, MD Ronnie M. Gravett, MD | Antiretroviral Therapy: Emerging Issues and Challenging Cases | Rajesh T. Gandhi, MD Charles Flexner, MD | Advances in HIV Treatment | Joseph J. Eron, Jr., MD Connie Benson, MD | Early Management of COVID-19 | Michael S. Saag, MD Glenn J. Treisman, MD, PhD | |
| Sunday, March 27, 2022 |
| 07:00 AM – 08:00 AM | Breakfast | |
| 08:00 AM – 08:10 AM | Introduction and Conference Goals | Mark S. Sulkowski, MD |
| 08:10 AM – 08:35 AM | Management Considerations for Hepatitis C | Susanna Naggie, MD, MHS |
| 08:35 AM – 09:00 AM | Reinfection and Cancer after Hepatitis C Cure | Arthur Y. Kim, MD |
| 09:00 AM – 09:20 AM | Panel Discussion / Questions and Answers | |
| 09:20 AM – 09:45 AM | Management Considerations for Hepatitis B | Chloe L. Thio, MD |
| 09:45 AM – 10:10 AM | Hepatitis B Cure: New Drugs, Novel Strategies | Jordan Feld, MD, MPH |
| 10:10 AM – 10:30 AM | Panel Discussion / Questions and Answers | |
| 10:30 AM – 10:45 AM | Break | |
| 10:45 AM – 11:10 AM | Approaches to Persons with HIV and Elevated Liver Enzymes | Kenneth E. Sherman, MD |
| 11:10 AM – 11:35 AM | Fatty Liver Disease in Persons With HIV | E. Turner Overton, MD |
| 11:35 AM – 11:55 AM | Panel Discussion / Questions and Answers | |
| 11:55 AM – 12:10 PM | Break | |
| 12:10 PM – 01:10 PM | Working Lunch - Case Presentations | Mark S. Sulkowski, MD and faculty panel |
| 01:15 PM – 01:45 PM | Faculty Roundtable Session 1* | |
| 01:50 PM – 02:20 PM | Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the four sessions)
Hepatitis C: Challenging Cases | Susanna Naggie, MD, MHS Arthur Y. Kim, MD | Hepatitis B and D: More Questions and Answers | Chloe Thio, MD Jordan Feld, MD, MPH | Fatty Liver Disease | E. Turner Overton, MD Kenneth E. Sherman, MD | |